Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory DiseasesLingfeng Chen, Guang Liang, Lin Ma et al.|Journal of Medicinal Chemistry|2024Cited by 6
MiR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1Jie Yu, Yu Chen|Research Square|2022Cited by 0